Tango Therapeutics has announced several leadership changes, appointing Matthew Gall as Chief Financial Officer, Yen-Ching Chua as Chief Development Operations Officer effective June 1, 2026, and ...
Additional key appointments add expertise in clinical operations, corporate strategy and project leadership - BOSTON, April 15, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a ...
This precision oncology developer reported a notable insider sale during a period of robust share price gains.
A festival that brings together dancers, musicians and people interested in learning more about Argentine tango music is ...
Listening to tango music enthralls the body into an emotional intensity that blends nostalgia, melancholy and raw passion.
Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
Biotech bank balances were again in focus Monday morning, with Tango Therapeutics cutting preclinical work to stretch its cash runway and Avalo Therapeutics outlining options for preserving its money.
The restaurant operators made the decision to leave their building and relocate when the landlord decided to sell it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results